Negotiating prices of drugs for rare diseases-Reference-Cited by-同舟云学术

Negotiating prices of drugs for rare diseases

Published:2016-08-31 Issue:10 Volume:94 Page:779-781
ISSN:0042-9686
Container-title:Bulletin of the World Health Organization
language:
Short-container-title:Bull. World Health Organ.

Author:

Henrard Séverine¹,Arickx Francis²

Affiliation:

1. Institute of Health and Society (IRSS), Université Catholique de Louvain, Clos Chapelle-aux-Champs, 30 B1.30.15, 1200 Brussels, Belgium.

2. National Institute for Health and Disability Insurance (RIZIV/INAMI), Brussels, Belgium.

Publisher

WHO Press

Subject

Public Health, Environmental and Occupational Health

Reference14 articles.

1. Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products.;Official Journal of the European Communities,2000

2. Council recommendation of 8 June 2009 on an action in the field of rare diseases (2009/C 151/02). Official J Eur Union. 2009 Jul 3;52:7–10. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:C:2009:151:TOC [cited 2016 Aug 16].

3. Global estimates of diabetes prevalence for 2013 and projections for 2035.;Guariguata;Diabetes Res Clin Pract,2014

4. Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems.;Graf von der Schulenburg;Eur J Health Econ,2015

5. Rare diseases and effective treatments: are we delivering?;Luzzatto;Lancet,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence empowering rare diseases: a bibliometric perspective over the last two decades;Orphanet Journal of Rare Diseases;2024-09-13

2. Make gene therapies more available by manufacturing them in lower-income nations;Nature;2024-07-17

3. A National Cancer Grid pooled procurement initiative, India;Bulletin of the World Health Organization;2023-09-01

4. Improving Access to Rare Disease Treatments: Subsidy, Pricing, and Payment Schemes;Management Science;2022-12-15

5. Burden and trends of multiple sclerosis in China from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019;BMJ Open;2022-12